`
`Drugs@FDA: FDA-Approved Drugs
`
`Drugs@FDA: FDA-Approved Drugs
`f SHARE (HTTPS :/IWWW.FACEBOOK.COM/SHARER/SHARER.PHP?U=HTTPS:/IWWW.ACCESSDATA.FDA.GOV/SCRIPTS/CDER/DAF/INDEX.CFM?
`FYFNI-OYFBVIEW PBOCFSS&APPI N9=9?1756!
`
`'fl TWEET (HTTPS://TWITTER.COM/INTENT/TWEET/?TEXT =DRUGS@FDA: FDA-APPROVED
`DRUGS&URL=HTTPS:/IWWW.A CCESSDATA .FDA.GOV/SCRI PTS/CDER/DAF/INDEX.CFM?EVENT=OVERVIEW.PROCESS&APPLN0=021756l
`
`±
`II EMAIL (MAILTO:?SUBJECT=DRUGS@FDA: FDA-APPROVED DRUGS&BODY=HTTPS ://WWW.A CCESSDATA.FDA.GOV/SCRIPTS/CDER/DA F/INDEX.CFM?
`EVENT =OVERVIEW.PROCESS&APPLNO=021756l
`
`New Drug Application (NOA): 021756
`Company: VALEANT PHARMS LLC
`
`II EMAIL (MAILTO:?SUBJ ECT =DRUGS@FDA: FDA APPROVED DRUG PRODUCTS&BODY=HTTP://WWW.ACCESSDATA.FDA.GOV/SCRIPTS/CDER/DAF/INDEX.CFM?
`EVENT =OVERVI EW.PROCESS%26VARAPPLNO=021 756l
`
`Products on NOA 021756
`
`csv
`
`Excel
`
`
`Drug
`Name
`
`Active
`Ingredients
`
`Strength
`
`Dosage Form/Route
`
`Marketing
`Status
`
`TE
`Code
`
`RLD
`
`RS
`
`MACUGEN
`
`PEGAPTANIB
`SODIUM
`
`EQ0.3MG
`ACID/0.09ML
`
`INJECTABLE;INTRAVITREAL
`
`Discontinued
`
`None
`
`Yes
`
`No
`
`Showing 1 to 1 of 1 entries
`
`AP-1:.iroval Date(~) and History, Letters, Labels, Reviews for NOA 021756
`
`Labels for NOA 021756
`
`V
`
`V
`
`V
`
`https://www.accessdata.fda.gov/scripts/cder/daf/index.dm?event=overview.process&ApplNo=021756
`
`1/1
`
`Novartis Exhibit 2283.001
`Regeneron v. Novartis, IPR2021-00816
`
`